Study of the Long-Term Effects of Radiation Therapy on Survivors of Rare Cancers

Background: Head and neck cancer (HNC) survivors represent a significant population, with numbers steadily increasing due to improved detection and treatment methods. Despite advancements, long-term effects of radiation therapy remain under-explored, resulting in a critical gap in understanding the comprehensive burden of late toxicities among these survivors. Research has mainly focused on acute treatment-related effects, while chronic symptoms like fatigue, insomnia, and various pain syndromes often persist for years post-treatment, negatively impacting quality of life. Collectively, the rarity of some cancer types complicates the study of long-term effects. Therefore, this review aims to synthesize existing data on the long-term consequences of radiation therapy on rare cancer survivors, emphasizing the need for systematic assessments and tailored follow-up strategies that can enhance survivorship care and improve patient outcomes. Materials and Methods: A comprehensive search was conducted across PubMed, Scopus, Google Scholar, American Roentgen Ray Society (ARRS), and the Journal of National Library of Medicine to perform this review. A systematic search strategy was employed using the keyword "long-term toxicity" to identify English-language articles published between ۲۰۱۷ and ۲۰۲۴. Out of the ۱۳ articles retrieved, three were selected for inclusion based on their relevance to the review's objectives. Data extracted from each article included the study's objective, methodology, primary findings, and limitations. A qualitative content analysis was employed to analyze the data. Results: This study demonstrates that a significant proportion of rare cancer survivors experience persistent symptoms years after diagnosis, including fatigue, sleep disturbances, and pain. In head and neck cancer, radiation therapy was associated with substantial long-term toxicity, such as dry mouth and osteoradionecrosis, highlighting the critical need for comprehensive long-term care and supportive interventions for all rare cancer survivors. Conclusion: Long-term follow-up exceeding five years is crucial, as significant late effects of radiotherapy can persist in patients considered cured, necessitating ongoing monitoring and management.

کلیدواژه ها:

Rare cancer ، long-term survivors ، radiation therapy ، treatment